KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Minority Interest (2016 - 2026)

Quest Diagnostics' Minority Interest history spans 18 years, with the latest figure at $300.0 million for Q1 2026.

  • On a quarterly basis, Minority Interest rose 809.09% to $300.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $300.0 million, a 809.09% increase, with the full-year FY2025 number at $36.0 million, up 2.86% from a year prior.
  • Minority Interest hit $300.0 million in Q1 2026 for Quest Diagnostics, up from $36.0 million in the prior quarter.
  • Over the last five years, Minority Interest for DGX hit a ceiling of $300.0 million in Q1 2026 and a floor of $33.0 million in Q1 2025.
  • Historically, Minority Interest has averaged $71.5 million across 5 years, with a median of $76.0 million in 2023.
  • Biggest five-year swings in Minority Interest: plummeted 57.14% in 2025 and later skyrocketed 809.09% in 2026.
  • Tracing DGX's Minority Interest over 5 years: stood at $77.0 million in 2022, then dropped by 1.3% to $76.0 million in 2023, then tumbled by 53.95% to $35.0 million in 2024, then rose by 2.86% to $36.0 million in 2025, then soared by 733.33% to $300.0 million in 2026.
  • Business Quant data shows Minority Interest for DGX at $300.0 million in Q1 2026, $36.0 million in Q4 2025, and $81.0 million in Q3 2025.